JP4587368B2 - Fermented malt beverage containing lactic acid bacteria having antiallergic function or malt substitute fermented beverage, and method for producing the same - Google Patents
Fermented malt beverage containing lactic acid bacteria having antiallergic function or malt substitute fermented beverage, and method for producing the same Download PDFInfo
- Publication number
- JP4587368B2 JP4587368B2 JP2004235642A JP2004235642A JP4587368B2 JP 4587368 B2 JP4587368 B2 JP 4587368B2 JP 2004235642 A JP2004235642 A JP 2004235642A JP 2004235642 A JP2004235642 A JP 2004235642A JP 4587368 B2 JP4587368 B2 JP 4587368B2
- Authority
- JP
- Japan
- Prior art keywords
- lactic acid
- malt
- fermented
- beverage
- acid bacteria
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Landscapes
- Distillation Of Fermentation Liquor, Processing Of Alcohols, Vinegar And Beer (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Alcoholic Beverages (AREA)
Description
本発明は、抗アレルギー機能を有する乳酸菌入り発酵麦芽飲料又は麦芽代替発酵飲料、及びその製造方法に関する。特に、発酵麦芽飲料又は麦芽代替発酵飲料の製造において、抗アレルギー活性を有する乳酸菌による乳酸発酵後に、酵母によるアルコール発酵を行うことにより、すっきりとした爽やかな酸味とまろやかな香味を持ち、かつ、抗アレルギー活性を有する乳酸菌を含有するようにした乳酸菌入り発酵麦芽飲料又は麦芽代替発酵飲料、及びその製造方法に関する。 The present invention relates to a fermented malt beverage containing lactic acid bacteria having an antiallergic function or a malt substitute fermented beverage, and a method for producing the same. In particular, in the production of fermented malt beverages or malt substitute fermented beverages, by performing alcoholic fermentation with yeast after lactic acid fermentation with lactic acid bacteria having antiallergic activity, it has a refreshing refreshing acidity and mellow flavor, and anti The present invention relates to a fermented malt beverage containing lactic acid bacteria or malt substitute fermented beverages containing lactic acid bacteria having allergic activity, and a method for producing the same.
ビールや発泡酒のような発酵麦芽飲料は、主原料として麦芽を、副原料として米、麦、コーン、スターチ等の澱粉質原料、及びこれにホップ、水を原料にして製造されるが、日本の酒税法においては、麦芽使用比率で比較すると、ビールは、水を除く麦芽の使用量が全原料中、67重量%以上と規定されている。一方、発泡酒には、上記原料の内、水を除く麦芽の使用量が50重量%以上66.7重量%未満及び、25重量%以上50重量%未満及び、25重量%未満の3種類が規定されている。 Fermented malt beverages such as beer and happoshu are produced using malt as the main ingredient, starchy ingredients such as rice, wheat, corn, and starch as the auxiliary ingredients, and hops and water as raw ingredients. In the liquor tax law, the amount of malt used in beer is defined as 67% by weight or more in all raw materials when compared with malt use ratio. On the other hand, there are three types of Happoshu, the amount of malt excluding water, which is 50 wt% or more and less than 66.7 wt%, 25 wt% or more and less than 50 wt%, and less than 25 wt%. It is prescribed.
また、最近、発酵麦芽飲料の麦芽に替えて、窒素化合物やミネラル含有率の高い原料を使用し、ビールや発泡酒のような発酵麦芽飲料の製造に類似する方法で、アルコール飲料を製造する麦芽代替発酵飲料が製造されている。このような麦芽代替発酵飲料は、日本の酒税法上は「雑酒」に分類される。日本の酒税法上、「雑酒」は、麦芽又は麦を原料の一部とした「発泡酒」と、発泡酒以外の「その他の雑酒」に分類される。ここで「その他の雑酒」は、麦芽又は麦を使用せず、マメ類、穀類などの植物タンパク質等を酵素分解した窒素源と糖化液を混合し、酵母によりアルコール発酵させるものである。 Recently, malt that produces alcoholic beverages using a method similar to the production of fermented malt beverages such as beer and happoshu, using raw materials with a high nitrogen content and mineral content instead of malt in fermented malt beverages. Alternative fermented beverages are manufactured. Such malt-substitute fermented beverages are classified as “miscellaneous sake” under Japanese liquor tax law. According to the Japanese liquor tax law, “Zozake” is classified into “Happoshu” using malt or wheat as a part of raw materials and “Other miscellaneous drinks” other than Happoshu. Here, “other miscellaneous sake” does not use malt or wheat but mixes a nitrogen source obtained by enzymatic decomposition of plant proteins such as legumes and cereals with a saccharified solution and performs alcoholic fermentation with yeast.
上記のように、発泡酒は、日本の酒税法上は、麦芽を原料の一部として用いた雑酒に属するものであるが、ビールも発泡酒も、いずれも麦芽の活性酵素や、カビ由来などの精製された酵素を用いて、麦芽や副原料である澱粉質を糖化させ、この糖化液を酵母によりアルコール発酵させて、アルコール、炭酸ガスに分解して、アルコール飲料としているものである点では共通している。従って、ビールの作り方も、発泡酒の作り方も、その基本においては、大きく変わるものでない。また、「その他の雑酒」に属する麦芽代替発酵飲料も、麦芽等の酵素分解に替えて、上記のような植物タンパク質等を酵素分解した窒素源と糖化液を混合し、酵母によりアルコール発酵させるものであり、ビールや発泡酒の作り方と基本的に大きく異なるものではなく、ビール又は発泡酒の製造装置を使用して、類似する方法で製造されるものである。 As mentioned above, Happoshu belongs to miscellaneous sake using malt as a raw material under Japanese liquor tax law. Both beer and Happoshu are derived from malt active enzymes and fungi. The saccharified malt and the auxiliary starch material are saccharified using a purified enzyme such as saccharified, and the saccharified solution is alcohol-fermented with yeast and decomposed into alcohol and carbon dioxide to produce an alcoholic beverage. Then it is common. Therefore, neither the method of making beer nor the method of making Happoshu has changed significantly. In addition, malt substitute fermented beverages belonging to “other miscellaneous sake” are also subjected to alcoholic fermentation with yeast by mixing a nitrogen source obtained by enzymatic decomposition of the above plant proteins and the saccharified solution instead of enzymatic decomposition of malt and the like. This is not basically different from the method of making beer or happoshu, but is produced in a similar manner using a beer or happoshu production apparatus.
近年、ビールや発泡酒のような発酵麦芽飲料において、消費者の味の多様化の要求から、種々の香味を有する発酵麦芽飲料の開発の試みが行われている。その香味の多様化のために微生物を利用する試みとして、例えば、特開平6−303959号公報には、麦芽や澱粉質副原料のような発泡酒の製造原料に黄麹菌や白麹菌によって調製した清酒の元や清酒醪を加えて、清酒風味の発泡酒を製造する方法や、発泡酒の製造原料にブドウ果汁、リンゴ果汁、その他の果汁に果実酒用酵母を発酵、増殖させた醪を添加してワイン風味或いはシードル風味を付与した発泡酒の製造方法について開示されている。また、特許第2727048号公報には、麦芽や澱粉質副原料のような発泡酒の製造原料から調製した糖化液に、白麹菌又はリゾープス菌を繁殖させて得た米麹、大麦麹又はトウモロコシ麹を使用して製造したクエン酸に富む元を添加して、クエン酸に富んだ風味を有する発泡酒を製造する方法について開示されている。 In recent years, in fermented malt beverages such as beer and happoshu, attempts have been made to develop fermented malt beverages having various flavors due to demands for diversification of consumer tastes. As an attempt to use microorganisms for diversification of the flavor, for example, in JP-A-6-303959, a raw material for producing happoshu such as malt and starchy auxiliary materials was prepared using yellow koji or white koji. A method for producing sake-flavored happoshu by adding sake brewer's sake and sake brewer's sake, as well as grape juice, apple juice and other fruit juice fermented and grown grapes as a raw material for happoshu Thus, a method for producing a sparkling liquor imparted with a wine flavor or a cider flavor is disclosed. Japanese Patent No. 2727048 discloses rice bran, barley koji, or corn koji obtained by breeding white koji mold or Rhizopus fungus in a saccharified solution prepared from a raw material for producing sparkling liquor such as malt and starchy auxiliary materials. A method for producing a sparkling liquor having a citric acid-rich flavor by adding a citric acid-rich source produced using
しかし、これらはいずれも清酒風味や果実酒風味等を付与した発泡酒の製造方法であって、麦芽や澱粉質副原料から製造される従来のビールや発泡酒とは、その香味上タイプの異なる発酵麦芽飲料の製造方法となっている。
また、古来より、ビールや発泡酒のような発酵麦芽飲料において、濾過後の発酵麦芽飲料中に酵母を含有させて、いわゆる酵母入り発酵麦芽飲料として、香味豊かな、かつ、まろみのある発酵麦芽飲料として製品化することが行われている。しかしながら、この酵母は、ビールや発泡酒のような発酵麦芽飲料の製造に使用されている発酵材料の範囲に留まるものであるから、その香味の改善の多様性の幅には限度がある。
However, these are all methods for producing a sparkling liquor imparted with a sake flavor, a fruit liquor flavor, etc., which are different in flavor and type from conventional beer and sparkling liquor produced from malt and starchy auxiliary materials. It is a method for producing fermented malt beverages.
Also, since ancient times, in fermented malt beverages such as beer and sparkling wine, yeast is contained in the filtered fermented malt beverage, and as a so-called yeast-containing fermented malt beverage, flavorful and mellow fermentation Commercialization as a malt beverage has been carried out. However, since this yeast remains within the range of fermentation materials used in the production of fermented malt beverages such as beer and happoshu, there is a limit to the variety of flavor improvements.
一方、乳酸菌は、清酒等の分野においては、その酒類の製造のための微生物として利用されている。しかし、ビールや発泡酒のような発酵麦芽飲料の製造においては、むしろ、汚染菌としてその混入を避けることが行われている。したがって、ビールや発泡酒のような発酵麦芽飲料の製造においては、乳酸菌の混入を避けるために、それを検出する手段(特開平7−289295号公報、特開平9−121896号公報、特開2003−251号公報、特表2002−521650号公報)や、それを除去する手段(特開2002−315562号公報、特開2003−144128号公報)等が種々開発されている。 On the other hand, lactic acid bacteria are used as microorganisms for the production of alcoholic beverages in the field of sake and the like. However, in the production of fermented malt beverages such as beer and happoshu, rather, contamination is avoided as a contaminating bacterium. Therefore, in the production of fermented malt beverages such as beer and sparkling liquor, means for detecting it in order to avoid contamination with lactic acid bacteria (JP-A-7-289295, JP-A-9-121896, JP2003). -251 gazette, JP-T-2002-521650 gazette), means for removing it (JP-A-2002-315562, JP-A-2003-144128) and the like have been developed.
他方、ビールのような発酵麦芽飲料において、乳酸菌を用いて、乳酸菌の産生する酸味を香味に利用する方法も知られている。その例として、ベルギーのランビック(lambic)ビールが知られている(宮地秀夫著「ビール醸造技術」株式会社食品産業新聞社(1999年12月28日)、P494−495)。このランビックビールは、酵母と醸造中に混入する乳酸菌とを利用し、該酵母と乳酸菌との混合状態の微生物により、従来のビールの発酵槽を用いた発酵様式により並列式に発酵を行わせて製造するものである。しかしながら、この方法は、たまたま混入する乳酸菌を利用するものであるから、乳酸菌の濃度のコントロールが難しく、味の安定性に問題があり、また、その発酵期間も長いという問題がある。 On the other hand, in fermented malt beverages such as beer, a method is also known in which lactic acid bacteria are used and the acidity produced by lactic acid bacteria is used as a flavor. For example, Belgian lambic beer is known (Hideo Miyaji, “Beer Brewing Technology”, Food Industry Newspaper Co., Ltd. (December 28, 1999), P494-495). This lambic beer uses yeast and lactic acid bacteria mixed during brewing, and allows the microorganisms in a mixed state of the yeast and lactic acid bacteria to be fermented in parallel in a fermentation manner using a conventional beer fermenter. To manufacture. However, since this method uses lactic acid bacteria which happens to be mixed, there is a problem that it is difficult to control the concentration of the lactic acid bacteria, there is a problem in the stability of the taste, and the fermentation period is also long.
そこで、糖液、果汁、麦芽汁、穀類の糖化液の1種以上を発酵原料として、酵母による発酵帯域と乳酸菌のような酸生成菌による発酵帯域とを直列的に連結して、複式発酵を行うことにより、爽快な酸味とエタノール発酵によって生成したエタノールによる芳醇さやボディを有する豊かな風味ないし香味を有する酒類等の発酵飲料を製造する方法が開発されている(特許第2888862号公報)。この方法は、酒類等の製造方法において、乳酸菌等の生成する爽快な酸味を利用するものであるが、これをビールのような発酵麦芽飲料の製造に適用した場合には、乳酸菌による発酵工程が入るために、発酵する際に生成するダイアセチルのコントロールを行わなければならないという必要がある。 Therefore, using one or more of sugar liquor, fruit juice, malt juice, and saccharified cereal as a fermentation raw material, the fermentation zone by yeast and the fermentation zone by acid-producing bacteria such as lactic acid bacteria are connected in series, and double fermentation is performed. A method has been developed for producing fermented beverages such as alcoholic beverages having a rich flavor or flavor with a refreshing sourness and ethanol produced by ethanol fermentation and a rich flavor or flavor (Japanese Patent No. 2888862). This method uses a refreshing sourness produced by lactic acid bacteria in a method for producing alcoholic beverages, etc., but when this method is applied to the production of fermented malt beverages such as beer, a fermentation process using lactic acid bacteria is required. In order to enter, it is necessary to control the diacetyl produced during fermentation.
一方、近年、飲食品等の分野において飲食品に生理活性物質のような成分を含有させて、機能性飲食品として利用することが盛んに行なわれている。その機能性の一つに抗アレルギー作用がある。この抗アレルギー作用を持つ物質の一つとして乳酸菌が知られている。種々の飲食品の製造に利用されている乳酸菌は、安全性の面から飲食品などへの応用が容易であり、抗アレルギー作用を持つ物質として有用な素材である。しかし、乳酸菌を抗アレルギー作用を持つ物質として、機能性飲食品の製造に利用する場合に、一概に乳酸菌といっても全ての乳酸菌に抗アレルギー作用を増強させる強い効果があるわけではなく、乳酸菌の利用にあたっては、有用な株の選択をすることが必須となってくる。 On the other hand, in recent years, in the field of foods and drinks and the like, food and drinks are actively used as functional foods and drinks by containing components such as physiologically active substances. One of its functions is antiallergic action. Lactic acid bacteria are known as one of the substances having this antiallergic action. Lactic acid bacteria used in the production of various foods and drinks are easy to apply to foods and drinks from the viewpoint of safety, and are useful materials as anti-allergic substances. However, when lactic acid bacteria are used for the production of functional foods and drinks as substances having anti-allergic action, even though lactic acid bacteria are generally referred to, not all lactic acid bacteria have a strong effect of enhancing anti-allergic action. When using, it is essential to select useful strains.
今までに、乳酸菌を抗アレルギーに利用する試みについては、いくつかのものが知られている。例えば、抗アレルギー乳酸菌として、Lactobacillus rhamnosus LGG株が知られており、妊婦に摂取させることにより、子供のアトピー性皮膚炎発症が抑制されることが示されている(ランセット、2001年、第357巻、1076頁)。また、乳酸菌を抗アレルギー剤として用いることについては、いくつかの特許公報でも開示されている。例えば、特開平9−2959号公報には、L.アシドフィルス、L.ブレビス、L.ブフネリ、及びL.カゼイ等の乳酸菌を添加してマウスリンパ球を培養した際のIgE産生量が30ng/ml以下のものを抗アレルギー剤として用いることについて、特開平10−309178号公報には、ビフィドバクテリウム・インファンティス、ビフィドバクテリウム・ブレーベ、ビフィドバクテリウム・ロンガム及びビフィドバクテリウム・ビフィダム等のビフィズス菌を特に食物アレルギーを治療するための抗アレルギー剤として用いることについて、及び、特開2000−95697号公報には、エンテロコッカス・フェカリス、ラクトバシルス・ロイテリーなどの乳酸菌をアレルギ性気管支喘息、アレルギ性鼻炎及びアトピ−性皮膚炎等のI型アレルギーの抑制剤として用いることについて、それぞれ開示されている。 To date, there are several known attempts to utilize lactic acid bacteria for anti-allergy. For example, the Lactobacillus rhamnosus LGG strain is known as an antiallergic lactic acid bacterium, and it has been shown that the onset of atopic dermatitis in children is suppressed by ingestion by pregnant women (Lancet, 2001, Vol. 357). 1076). Further, the use of lactic acid bacteria as an antiallergic agent is also disclosed in several patent publications. For example, Japanese Patent Laid-Open No. 9-2959 discloses L. Acidophilus, L. Brevis, L. Buchneri and L. Japanese Patent Application Laid-Open No. 10-309178 discloses the use of an anti-allergic agent having an IgE production amount of 30 ng / ml or less when mouse lymphocytes are cultured with lactic acid bacteria such as casei added. Use of bifidobacteria such as Infantis, Bifidobacterium breve, Bifidobacterium longum and Bifidobacterium bifidum as anti-allergic agents for treating food allergies, and No. 95697 discloses the use of lactic acid bacteria such as Enterococcus faecalis and Lactobacillus reuteri as inhibitors of type I allergies such as allergic bronchial asthma, allergic rhinitis and atopic dermatitis, respectively. .
乳酸菌のもつ抗アレルギー作用を飲食品の製造に利用することも知られている。すなわち、抗アレルギー効果を有する飲食品として、上述のように特定の乳酸菌を用いたヨーグルトや乳酸菌飲料が、抗アレルギー効果を有する飲食物として一部実用化されている。しかし、このような飲食品類は、もともと乳酸菌を使用してその飲食品を製造していた分野のものであり、前記のものは該飲食品の製造に用いる乳酸菌に、抗アレルギー活性のものを選定したという範囲のものであり、場合によっては、乳酸菌の抗アレルギー効果のみを追求し、味覚の点では、もう一つ満足の行かないものなどもあって、乳酸菌のもつ抗アレルギー活性の利用が、乳酸発酵の特徴及び乳酸菌のもつ抗アレルギー活性をその機能及び味覚の上で、積極的に利用しえたものではなかった。 It is also known to use the antiallergic action of lactic acid bacteria for the production of food and drink. That is, as foods and drinks having an antiallergic effect, yogurt and lactic acid bacteria drinks using specific lactic acid bacteria as described above are partially put into practical use as foods and drinks having an antiallergic effect. However, such foods and drinks are from the field where the foods and drinks were originally manufactured using lactic acid bacteria, and the above-mentioned foods are selected from those having antiallergic activity for the lactic acid bacteria used in the production of the foods and drinks. In some cases, pursuing only the anti-allergic effect of lactic acid bacteria, there is another thing that does not satisfy in terms of taste, the use of anti-allergic activity of lactic acid bacteria, The characteristics of lactic acid fermentation and the antiallergic activity of lactic acid bacteria were not positively utilized in terms of their functions and taste.
ところで、前記のような酵母によるアルコール発酵させた発酵麦芽飲料又は麦芽代替発酵飲料の製造において、飲食品材料として安全に利用できる乳酸菌を用いて、乳酸発酵による爽やかな酸味を持つ特有の味覚と、前記のような抗アレルギー活性を利用して、香味に優れ、かつ、有用な機能性を有する発酵麦芽飲料又は麦芽代替発酵飲料を製造することが考えられる。しかし、従来、発酵麦芽飲料又は麦芽代替発酵飲料の製造工程において、乳酸菌を添加して、乳酸発酵を行なった場合に産生するダイアセチル等の問題から、抗アレルギー活性のような機能性を有し、しかも調和のとれたまろやかな酸味と穏やかな香味を実現できる乳酸菌入りの発酵麦芽飲料又は麦芽代替発酵飲料は存在しなかった。 By the way, in the production of fermented malt beverages or malt substitute fermented beverages that have been alcoholic fermented with yeast as described above, using lactic acid bacteria that can be safely used as food and beverage materials, a unique taste with a refreshing acidity by lactic acid fermentation, It is conceivable to produce a fermented malt beverage or a malt substitute fermented beverage having excellent flavor and useful functionality by utilizing the antiallergic activity as described above. However, conventionally, in the production process of fermented malt beverages or malt substitute fermented beverages, it has functionality such as antiallergic activity due to problems such as diacetyl produced when lactic acid bacteria are added and lactic acid fermentation is performed. Moreover, there has been no fermented malt beverage or malt substitute fermented beverage containing lactic acid bacteria that can realize a harmonious, mild acidity and mild flavor.
本発明の課題は、発酵麦芽飲料又は麦芽代替発酵飲料の製造方法において、抗アレルギー活性を有する乳酸菌による乳酸発酵を利用し、抗アレルギー機能を具備し、かつ、乳酸発酵によるすっきりとした爽やかな酸味とまろやかな香味を持つ、乳酸菌入り発酵麦芽飲料又は麦芽代替発酵飲料、及びその製造方法を提供することにある。 An object of the present invention is to use a lactic acid fermentation by a lactic acid bacterium having antiallergic activity in a method for producing a fermented malt beverage or a malt substitute fermented beverage, having an antiallergic function, and having a refreshing refreshing acidity by lactic acid fermentation It is to provide a fermented malt beverage containing lactic acid bacteria or a malt substitute fermented beverage having a mellow flavor, and a method for producing the same.
本発明者は、上記課題を解決すべく鋭意研究を重ねたところ、発酵麦芽飲料又は麦芽代替発酵飲料の製造において、抗アレルギー活性を有する乳酸菌を添加し、乳酸発酵を行なった後、酵母によるアルコール発酵を行ない、かつ、発酵麦芽飲料又は麦芽代替発酵飲料のダイアセチル濃度をビール又は発泡酒の閾値以下に抑制することにより、乳酸発酵由来の調和のとれた爽快でまろやかな酸味と酵母によるアルコール発酵由来の穏やかな風味・香味を有し、かつ、乳酸菌の抗アレルギー活性による抗アレルギー機能を有する乳酸菌入り発酵麦芽飲料又は麦芽代替発酵飲料が製造できることを見い出し、本発明を完成するに至った。 The present inventor has made extensive studies to solve the above problems, and in the manufacture of fermented malt beverages or malt substitute fermented beverages, after adding lactic acid bacteria having antiallergic activity and performing lactic acid fermentation, alcohol by yeast Alcohol fermentation by yeast with harmonious, refreshing and mild acidity derived from lactic acid fermentation by suppressing the diacetyl concentration of fermented malt beverage or malt substitute fermented beverage below the threshold of beer or happoshu It has been found that a fermented malt beverage containing lactic acid bacteria or a malt substitute fermented beverage having a mild flavor and flavor derived from lactic acid bacteria and having an antiallergic function due to the antiallergic activity of lactic acid bacteria can be produced, and the present invention has been completed.
すなわち、本発明においては、発酵麦芽飲料や麦芽代替発酵飲料の製造において、抗アレルギー活性を有する乳酸菌を利用して、発酵麦芽飲料や麦芽代替発酵飲料に、抗アレルギー機能を具備させると共に、該発酵麦芽飲料や麦芽代替発酵飲料の製造工程において、該乳酸菌による乳酸発酵を行なった後に、酵母によるアルコール発酵を行なうことで、乳酸発酵由来の酸味が、アルコール発酵由来の穏やかな風味・香味と相俟って、調和のとれた爽快でまろやかな酸味とすることができ、更に、乳酸発酵によるダイアセチルの生成を極力抑え、かつ、該乳酸発酵後に酵母によるアルコール発酵を行うことで、酵母のもつダイアセチル還元能の作用により、ダイアセチルを大きく低減することにより、ダイアセチル濃度をビール又は発泡酒の閾値0.1mg/l以下に抑制することにより、異臭の代表的な成分であるダイアセチルのような異臭成分を極力低減した清涼感のある、爽やかな酸味を有した発酵麦芽飲料又は麦芽代替発酵飲料を製造することが可能であることを見い出し、本発明をなした。 That is, in the present invention, in the production of fermented malt beverages and malt substitute fermented beverages, the fermented malt beverages and malt substitute fermented beverages are provided with an antiallergic function by using lactic acid bacteria having antiallergic activity, and the fermentation In the production process of malt beverages and malt substitute fermented beverages, after performing lactic acid fermentation with the lactic acid bacteria, by performing alcoholic fermentation with yeast, the acidity derived from lactic acid fermentation is compatible with the mild flavor and flavor derived from alcoholic fermentation Therefore, it is possible to achieve a harmonious, refreshing and mellow acidity, and further suppress the production of diacetyl by lactic acid fermentation as much as possible, and by performing alcoholic fermentation by yeast after the lactic acid fermentation, Diacetyl concentration is greatly reduced by the action of acetyl reducing ability, so that the concentration of diacetyl is the threshold of beer or happoshu. Fermented malt drink or malt substitute fermented drink with a refreshing sour taste with a refreshing sensation by reducing as much as possible the off-flavor components such as diacetyl, which is a typical off-flavor component, by suppressing to 0.1 mg / l or less It was found possible to manufacture the present invention, and the present invention was made.
本発明において、乳酸発酵によるダイアセチルの生成を抑える為に、乳酸発酵を、炭酸ガスや窒素ガスのような不活性ガスを置換した雰囲気により、嫌気性条件の乳酸発酵管理下に行い、ダイアセチル濃度をビール又は発泡酒の閾値以下に抑制する方法を採用することができる。また、ダイアセチルの産生、残存を極力防止するために、アルコール発酵における酵母として、上面発酵酵母を用いアルコール発酵におけるダイアセチルの低減を大きくすることができる。 In the present invention, in order to suppress the production of diacetyl due to lactic acid fermentation, lactic acid fermentation is performed under anaerobic lactic acid fermentation control in an atmosphere in which an inert gas such as carbon dioxide or nitrogen gas is substituted. A method of suppressing the concentration below the threshold value of beer or happoshu can be employed. Moreover, in order to prevent the production | generation and residual of diacetyl as much as possible, the reduction | restoration of diacetyl in alcohol fermentation can be enlarged using top fermentation yeast as yeast in alcohol fermentation.
本発明において、発酵麦芽飲料又は麦芽代替発酵飲料に、アレルギー機能を付与するための抗アレルギー活性を有する乳酸菌としては、乳酸菌が、卵白アルブミンで感作させたマウス脾臓由来リンパ球を卵白アルブミン含有培地に懸濁し被検乳酸菌を添加して培養した場合に、被検乳酸菌としてLactobacillus paracasei KW3110株を用いた場合に比較して、50%以上のインターロイキン12産生量を示し、且つ、乳酸菌無添加コントロールの50%未満のインターロイキン4産生量を示す高抗アレルギー活性を示す乳酸菌を挙げることができ、該乳酸菌としては具体的には、Lactobacillus paracasei KW3110株、Lactobacillus plantarum KW4110株、Lactobacillus paracasei KW3925株、Lactobacillus paracasei KW3926株、又はStreptococcus salivarius KW3210を挙げることができる。 In the present invention, as a lactic acid bacterium having antiallergic activity for imparting allergic function to fermented malt beverage or malt substitute fermented beverage, spleen derived from mouse spleen sensitized with ovalbumin by lactic acid bacteria is a medium containing ovalbumin When the test lactic acid bacterium is added to the suspension and cultured, Lactobacillus paracasei KW3110 strain is used as the test lactic acid bacterium, and the amount of interleukin 12 produced is 50% or more. Lactic acid bacteria exhibiting high anti-allergic activity and showing less than 50% of interleukin 4 production amount of Lactobacillus paracasei KW3110, Lactobacillus plantarum KW4110, Lactobacillus paracasei KW3925, Lactobacillus paracasei KW3926 strain or Streptococcu s salivarius KW3210.
本発明により、常温での長期保存に対して乳酸菌の抗アレルギー活性の低下が生じない発酵麦芽飲料又は麦芽代替発酵飲料を製造することが可能になる。すなわち、本発明の製造方法で提供される発酵麦芽飲料又は麦芽代替発酵飲料は、常温で、製造後の市場滞留期間に相当する製造後6ヶ月以内の期間を経過した該発酵麦芽飲料中又は該麦芽代替発酵飲料中の乳酸菌が示す前記インターロイキン12産生量及びインターロイキン4の産生量が、上記の乳酸菌のインターロイキン12産生量及びインターロイキン4の産生量の範囲内にあり、常温での長期保存に対して抗アレルギー機能を有する乳酸菌入り発酵麦芽飲料又は麦芽代替発酵飲料を提供することが可能である。 The present invention makes it possible to produce a fermented malt beverage or a malt substitute fermented beverage that does not cause a decrease in the antiallergic activity of lactic acid bacteria during long-term storage at room temperature. That is, the fermented malt beverage or malt substitute fermented beverage provided by the production method of the present invention is at room temperature, in the fermented malt beverage that has passed a period of 6 months or less corresponding to the market residence period after production, or the The production amount of the interleukin 12 and the production amount of the interleukin 4 indicated by the lactic acid bacteria in the malt alternative fermented beverage are within the range of the production amount of the interleukin 12 and the production of the interleukin 4 of the lactic acid bacteria. It is possible to provide a fermented malt beverage containing lactic acid bacteria or a malt substitute fermented beverage having an antiallergic function for preservation.
すなわち具体的には本発明は、発酵麦芽飲料又は麦芽代替発酵飲料の製造方法において、発酵原料溶液に、卵白アルブミンで感作させたマウス脾臓由来リンパ球を卵白アルブミン含有培地に懸濁し被検乳酸菌を添加して培養した場合に、被検乳酸菌としてLactobacillus paracasei KW3110株を用いた場合に比較して、50%以上のインターロイキン12産生量を示し、且つ、乳酸菌無添加コントロールの50%未満のインターロイキン4産生量を示す高抗アレルギー活性を示す乳酸菌を添加し、嫌気性条件の乳酸発酵管理下において乳酸発酵を行なった後、上面発酵酵母を用いて酵母によるアルコール発酵を行うことにより、発酵麦芽飲料又は麦芽代替発酵飲料のダイアセチル濃度をビール又は発泡酒の閾値0.1mg/l以下に抑制し、かつ、発酵麦芽飲料又は麦芽代替発酵飲料が、300〜3000mg/Lの乳酸と、発酵麦芽飲料又は麦芽代替発酵飲料100mlあたり、10 9 〜10 11 個の乳酸菌を含むように調製することを特徴とする抗アレルギー機能を有する乳酸菌入り発酵麦芽飲料又は麦芽代替発酵飲料の製造方法(請求項1)からなる。
Specifically, the present invention relates to a method for producing a fermented malt beverage or a malt substitute fermented beverage, wherein a mouse spleen-derived lymphocyte sensitized with ovalbumin is suspended in an ovalbumin-containing medium in a fermentation raw material solution, and a test lactic acid bacterium When Lactobacillus paracasei KW3110 strain is used as a test lactic acid bacterium, the amount of interleukin 12 produced is 50% or more and less than 50% of the lactic acid bacterium-free control. Fermented malt by adding lactic acid bacteria showing high anti-allergic activity indicating the production amount of leukin 4 and performing lactic acid fermentation under lactic acid fermentation control under anaerobic conditions, followed by alcohol fermentation with yeast using top fermentation yeast diacetyl concentration of beverage or malt substitute fermented beverage suppressed below a threshold 0.1 mg / l of beer or malt liquors, and Anti fermentation malt beverage or malt substitute fermented beverage to a lactic acid 300~3000mg / L, fermented malt beverage or malt substitute fermented beverages per 100ml, wherein the preparation to contain 109 to 1011 pieces of lactic acid bacteria It comprises a method for producing a fermented malt beverage containing lactic acid bacteria having an allergic function or a malt substitute fermented beverage (Claim 1) .
また本発明は、乳酸発酵に用いる高抗アレルギー活性を示す乳酸菌が、Lactobacillus paracasei KW3110株、Lactobacillus plantarum KW4110株、Lactobacillus paracasei KW3925株、又はLactobacillus paracasei KW3926株であることを特徴とする請求項1記載の抗アレルギー機能を有する乳酸菌入り発酵麦芽飲料又は麦芽代替発酵飲料の製造方法(請求項2)からなる。
The present invention, lactic acid bacteria showing high antiallergic activity that used in lactic acid fermentation, Lactobacillus paracasei KW3110 strain, Lactobacillus plantarum KW4110 strain, Lactobacillus paracasei KW3925 strain, or claim 1, wherein it is a Lactobacillus paracasei KW3926 strain A fermented malt beverage containing lactic acid bacteria having an antiallergic function or a method for producing a malt substitute fermented beverage ( Claim 2) .
本発明の発酵麦芽飲料又は麦芽代替発酵飲料の製造方法によれば、ビールや発泡酒等の発酵麦芽飲料又は麦芽代替発酵飲料であって、すっきり爽快でまろやかな酸味と穏やかな香味を付与することができ、しかも抗アレルギー活性を有する乳酸菌の共存により、抗アレルギー機能性も併せ持った発酵麦芽飲料又は麦芽代替発酵飲料を製造することができる。更に、本発明の発酵麦芽飲料又は麦芽代替発酵飲料の製造方法は、常温での長期保存に対して乳酸菌の抗アレルギー活性低下が生じない発酵麦芽飲料又は麦芽代替発酵飲料の提供が可能になる。 According to the method for producing a fermented malt beverage or a malt substitute fermented beverage of the present invention, it is a fermented malt beverage such as beer or sparkling liquor or a malt substitute fermented beverage, which provides a refreshing and refreshing mellow acidity and a mild flavor. In addition, by the coexistence of lactic acid bacteria having antiallergic activity, a fermented malt beverage or a malt substitute fermented beverage having antiallergic functionality can be produced. Furthermore, the method for producing a fermented malt beverage or a malt substitute fermented beverage of the present invention can provide a fermented malt beverage or a malt substitute fermented beverage that does not cause a decrease in the antiallergic activity of lactic acid bacteria with respect to long-term storage at room temperature.
また、本発明の発酵麦芽飲料又は麦芽代替発酵飲料の製造方法によれば、乳酸発酵、そして酵母によるアルコール発酵によって得られた発酵麦芽飲料又は麦芽代替発酵飲料を、別途製造した、乳酸発酵を行っていない、通常の発酵麦芽飲料又は麦芽代替発酵飲料の製法により製造された発酵麦芽飲料又は麦芽代替発酵飲料により調合し、目的とする香味に調整することが可能になる。また、その際、最終的な乳酸菌量を100mlあたり、109〜1011個とするために、別途培養し、生成した同じ菌を添加して調整することも可能となる。 Moreover, according to the method for producing a fermented malt beverage or a malt substitute fermented beverage of the present invention, a fermented malt beverage or a malt substitute fermented beverage obtained by lactic acid fermentation and alcohol fermentation by yeast is separately produced, and lactic acid fermentation is performed. It is possible to prepare a fermented malt beverage or a malt substitute fermented beverage produced by a method for producing a normal fermented malt beverage or a malt substitute fermented beverage, and to adjust the flavor to the target. At that time, in order to obtain a final amount of lactic acid bacteria of 10 9 to 10 11 per 100 ml, it is also possible to adjust by adding the same bacteria that are separately cultured and generated.
本発明は、発酵麦芽飲料又は麦芽代替発酵飲料の製造方法において、抗アレルギー活性を有する乳酸菌を添加し、乳酸発酵を行なった後、酵母によるアルコール発酵を行ない、かつ、発酵麦芽飲料又は麦芽代替発酵飲料のダイアセチル濃度をビール又は発泡酒の閾値0.1mg/l以下に抑制することにより、乳酸発酵由来の調和のとれた爽快でまろやかな酸味と酵母によるアルコール発酵由来の穏やかな風味・香味を有し、かつ、乳酸菌の抗アレルギー活性による抗アレルギー機能を有する乳酸菌入り発酵麦芽飲料又は麦芽代替発酵飲料を製造することよりなる。 The present invention relates to a method for producing a fermented malt beverage or a malt substitute fermented beverage. After adding lactic acid bacteria having antiallergic activity and performing lactic acid fermentation, alcohol fermentation with yeast is performed, and fermented malt beverage or malt substitute ferment By controlling the diacetyl concentration of the beverage to be below the threshold of 0.1 mg / l for beer or happoshu, a harmonious, refreshing and mellow acidity derived from lactic acid fermentation and a mild flavor and flavor derived from yeast alcohol fermentation And producing a fermented malt beverage containing lactic acid bacteria or a malt substitute fermented beverage having an antiallergic function due to the antiallergic activity of lactic acid bacteria.
本発明の発酵麦芽飲料又は麦芽代替発酵飲料の製造方法で、乳酸発酵に用いる乳酸菌は、抗アレルギー活性を有する乳酸菌であり、該乳酸菌としては、卵白アルブミンで感作させたマウス脾臓由来リンパ球を卵白アルブミン含有培地に懸濁し被検乳酸菌を添加して培養した場合に、被検乳酸菌としてLactobacillus paracasei KW3110株を用いた場合に比較して、50%以上のインターロイキン12産生量を示し、且つ、乳酸菌無添加コントロールの50%未満のインターロイキン4産生量を示す高抗アレルギー活性を示す乳酸菌を挙げることができる。また、その活性を長期間維持することが可能な乳酸菌であることが好ましい。該乳酸菌としては、具体的には、Lactobacillus paracasei KW3110株、Lactobacillus plantarum KW4110株、Lactobacillus paracasei KW3925株、Lactobacillus paracasei KW3926株、又はStreptococcus salivarius KW3210などの高抗アレルギー活性を示す乳酸菌を挙げることができる。 In the method for producing a fermented malt beverage or a malt substitute fermented beverage of the present invention, the lactic acid bacteria used for lactic acid fermentation are lactic acid bacteria having antiallergic activity, and the lactic acid bacteria include mouse spleen-derived lymphocytes sensitized with ovalbumin. When suspended in an ovalbumin-containing medium and added with a test lactic acid bacterium and cultured, Lactobacillus paracasei KW3110 strain is used as the test lactic acid bacterium, showing an interleukin 12 production amount of 50% or more, and The lactic acid bacteria which show the high antiallergic activity which show the production amount of interleukin 4 of less than 50% of lactic acid bacteria addition control can be mentioned. Moreover, it is preferable that it is a lactic acid bacterium which can maintain the activity for a long period of time. Specific examples of the lactic acid bacteria include Lactobacillus paracasei KW3110 strain, Lactobacillus plantarum KW4110 strain, Lactobacillus paracasei KW3925 strain, Lactobacillus paracasei KW3926 strain or Streptococcus salivarius KW3210.
本発明において、乳酸発酵に用いる高抗アレルギー活性を有する乳酸菌を取得するには、アレルゲンで感作させた動物脾臓由来リンパ球を当該アレルゲン含有培地に懸濁し被検乳酸菌を添加して培養し、被検乳酸菌としてLactobacillus paracasei KW3110株を用いた場合と同等、或いはL. paracasei KW3110株を用いた場合に比較して、50%以上のTh1誘導サイトカイン産生量を示し、且つ、乳酸菌無添加コントロールの50%未満のインターロイキン4生成量を示す乳酸菌を分離し、高抗アレルギー活性を有する乳酸菌を取得する。 In the present invention, in order to obtain a lactic acid bacterium having high antiallergic activity used for lactic acid fermentation, animal spleen-derived lymphocytes sensitized with allergen are suspended in the allergen-containing medium, added with a test lactic acid bacterium, and cultured. 50% or more of Th1-induced cytokine production as compared to the case of using Lactobacillus paracasei KW3110 as a test lactic acid bacterium or 50% or more compared to the case of using L. paracasei KW3110 A lactic acid bacterium having an interleukin 4 production amount of less than% is isolated to obtain a lactic acid bacterium having high antiallergic activity.
すなわち、公知の乳酸菌の菌株或いは新しく分離した乳酸菌の菌株を用いて、卵白アルブミンで感作させたマウス脾臓由来リンパ球を卵白アルブミン含有培地に懸濁したものに該乳酸菌を添加して培養し、基本的には、被検乳酸菌としてL.paracasei KW3110株を用いた場合と同等、或いはL.paracasei KW3110株を用いた場合に比較して、50%以上のインターロイキン12産生量を示し、且つ、乳酸菌無添加コントロールの50%未満のインターロイキン4生成量を示す乳酸菌を分離することにより取得することができる。前記のとおり、本発明において有効成分として用いる乳酸菌は、種々の公知の或いは新たに分離した乳酸菌の中から、in vitroにおける抗アレルギー活性を評価する実験方法を行うことにより、本発明の指標を基準に当業者が容易に選択し取得することができる。 That is, using a known lactic acid bacterium strain or a newly isolated lactic acid bacterium strain, mouse spleen-derived lymphocytes sensitized with ovalbumin were suspended in an ovalbumin-containing medium and cultured, Basically, L. as a test lactic acid bacterium. Equivalent to using paracasei KW3110 strain or L. Acquired by isolating lactic acid bacteria that show 50% or more interleukin 12 production and less than 50% interleukin 4 production of the lactic acid bacteria-free control compared to when paracasei KW3110 strain is used be able to. As described above, the lactic acid bacterium used as an active ingredient in the present invention is based on the index of the present invention by carrying out an experimental method for evaluating the antiallergic activity in vitro among various known or newly isolated lactic acid bacteria. A person skilled in the art can easily select and obtain the data.
本発明において、乳酸発酵に用いる、高抗アレルギー活性を有する乳酸菌は、例えばL.paracasei KW3110株は、L.casei L14株として、日本乳業技術協会から入手することができる。なお、日本乳業技術協会の記載によれば、L14株はL.caseiとの記載があるが、本発明者らがQUALICON社製リボプリンターを用いたRFLP(Restriction Flagment Length Polymorphism)及びAFLP(Amplified Flagment Length Polymorphism)を用いて解析したところ、当該株はL.paracaseiと判断されたため、本発明においてはL.paracaseiと記載した。本発明で抗アレルギー用組成物の有効成分として使用されるL.paracasei KW3110は、上記のとおり日本乳業技術協会から入手することができるが、更に、特許微生物の寄託のためのブダペスト条約に基く、国際寄託当局である独立行政法人産業技術総合研究所特許生物寄託センターに、FERM BP−08634として寄託されている。 In the present invention, lactic acid bacteria having high antiallergic activity used for lactic acid fermentation are exemplified by L. The paracasei KW3110 strain can be obtained from the Japan Dairy Industry Association as the L.casei L14 strain. According to the description of the Japan Dairy Technology Association, Although there is a description of casei, when the present inventors analyzed using RFLP (Restriction Fragment Length Polymorphism) and AFLP (Amplified Fragment Length Polymorphism) using a QUALICON riboprinter, the strain was found to be L. casei. Since it was determined to be paracasei, L. Indicated as paracasei. L. used as an active ingredient of the antiallergic composition in the present invention. paracasei KW3110 can be obtained from the Japan Dairy Industry Association as described above, but based on the Budapest Treaty for the Deposit of Patent Microorganisms, the International Depository Agency, National Institute of Advanced Industrial Science and Technology, Patent Biological Deposit Center Has been deposited as FERM BP-08634.
また、本発明で乳酸発酵に用いる、高抗アレルギー活性を有する乳酸菌のL.plantarum KW4110株はL.plantarum JCM1149株として、L.paracasei KW3926株はL.paracasei JCM8132株として、JCM(理化学研究所微生物系統保存施設)から入手することができ、更に、L.paracasei KW3925株はL.paracasei NRIC1917株として、NRIC(東京農業大学)から入手することができる。 In addition, L. lactic acid bacteria having high antiallergic activity used for lactic acid fermentation in the present invention are used. plantarum KW4110 strain plantarum JCM1149 strain, The paracasei KW3926 strain Paracasei JCM8132 strain can be obtained from JCM (RIKEN Microbial System Storage Facility). paracasei KW3925 strain It can be obtained from NRIC (Tokyo University of Agriculture) as paracasei NRIC1917.
本発明の発酵麦芽飲料又は麦芽代替発酵飲料の製造方法においては、該抗アレルギー活性を有する乳酸菌を用いて、乳酸発酵を行ない、その後酵母によるアルコール発酵を行なう。本発明の発酵麦芽飲料又は麦芽代替発酵飲料の製造方法において、乳酸菌及び酵母によって資化可能な発酵原料として、オリゴ糖を含む各資化性糖、果汁、麦汁、穀類、を原料とした糖化液の1種またはそれ以上を主としてなる発酵原料液を用いることができる。特に、ビールや発泡酒のような発酵麦芽飲料の場合は、麦汁を用いる。麦汁製造の際の仕込工程は、通常の行われている工程が採用される。すなわち、ビールや発泡酒のような発酵麦芽飲料又は麦芽代替発酵飲料の製造に通常行われている工程が採用される。但し、乳酸発酵に用いる麦汁は多くの乳酸菌に対して静菌作用を持つホップを添加しない方が望ましい。ホップ入りの爽快な味覚のビール若しくは発泡酒とするために、乳酸発酵後にホップ入りの麦汁を追加して酵母発酵することや、充填前に異性化ホップを添加することが望ましい。 In the method for producing the fermented malt beverage or malt substitute fermented beverage of the present invention, lactic acid fermentation is performed using the lactic acid bacteria having the antiallergic activity, and then alcohol fermentation with yeast is performed. In the method for producing a fermented malt beverage or malt substitute fermented beverage of the present invention, as a fermentation raw material that can be assimilated by lactic acid bacteria and yeast, saccharification using assimilation sugars, fruit juice, wort, and grains containing oligosaccharides as raw materials A fermentation raw material liquid mainly composed of one or more of the liquids can be used. In particular, in the case of fermented malt beverages such as beer and happoshu, wort is used. The process currently performed is employ | adopted for the preparation process in the case of wort manufacture. That is, the process normally performed for manufacture of fermented malt drinks, such as beer and happoshu, or malt substitute fermented drinks is employ | adopted. However, it is desirable that the wort used for lactic acid fermentation does not add hops having a bacteriostatic action against many lactic acid bacteria. In order to make a beer or a sparkling liquor with a refreshing taste of hops, it is desirable to add yeast wort with hops after lactic acid fermentation, and to add isomerized hops before filling.
乳酸発酵の条件としては、基本的には、通常の乳酸発酵の発酵条件を採用することができる。すなわち、適切な乳酸発酵を行うために、使用する菌に適した温度条件を採用し、発酵中はpHを制御して、菌自身が生成した乳酸によるpH低下により乳酸発酵が阻害されないようにすることが望ましい。 As conditions for lactic acid fermentation, basically, fermentation conditions for normal lactic acid fermentation can be employed. That is, in order to perform an appropriate lactic acid fermentation, a temperature condition suitable for the bacterium used is adopted, and the pH is controlled during the fermentation so that the lactic acid fermentation is not inhibited by the pH reduction due to the lactic acid produced by the bacterium itself. It is desirable.
本発明の発酵麦芽飲料又は麦芽代替発酵飲料の製造方法においては、発酵麦芽飲料又は麦芽代替発酵飲料のダイアセチル濃度をビール又は発泡酒の閾値0.1mg/l以下に抑制することが重要である。そのためには、抗アレルギー機能を有する乳酸菌による乳酸発酵において産生するダイアセチル濃度を極力減少させる必要がある。その方法としては、嫌気性条件の乳酸発酵管理により、ダイアセチルの生成を抑制する。例えば、乳酸発酵の際、CO2、N2又は希ガス等の不活性ガス等で置換した雰囲気を作り、高度の嫌気性条件下とすることで、乳酸発酵後のダイアセチルの生成を最小限に抑えることが可能になる。 In the method for producing a fermented malt beverage or a malt substitute fermented beverage of the present invention, it is important to suppress the diacetyl concentration of the fermented malt beverage or the malt substitute fermented beverage to a threshold value of 0.1 mg / l or less for beer or happoshu. . For that purpose, it is necessary to reduce as much as possible the concentration of diacetyl produced in lactic acid fermentation by lactic acid bacteria having an antiallergic function. As the method, the production of diacetyl is suppressed by lactic acid fermentation management under anaerobic conditions. For example, at the time of lactic acid fermentation, an atmosphere substituted with an inert gas such as CO 2 , N 2 or a rare gas is created, and the formation of diacetyl after lactic acid fermentation is minimized by making it an highly anaerobic condition. Can be suppressed.
本発明の発酵麦芽飲料又は麦芽代替発酵飲料の製造方法において、ダイアセチル濃度を減少させる方法として、アルコール発酵に用いる酵母を上面発酵酵母とすることで、乳酸発酵で生成するダイアセチルを最終的に閾値以下までに低減することも可能である。上面発酵酵母は、下面発酵酵母と比較して高温で発酵させるため、ダイアセチルの還元能が高いことが知られている。 In the method for producing a fermented malt beverage or a malt substitute fermented beverage of the present invention, as a method of reducing the diacetyl concentration, the yeast used for alcoholic fermentation is top fermented yeast, so that diacetyl produced by lactic acid fermentation is finally obtained. It is also possible to reduce to below the threshold. It is known that the top fermenting yeast is fermented at a higher temperature than the bottom fermenting yeast, and therefore has a high diacetyl reducing ability.
本発明の発酵麦芽飲料又は麦芽代替発酵飲料の製造方法においては、乳酸菌による乳酸発酵後に、酵母によるアルコール発酵を行なう。この酵母によるアルコール発酵により、乳酸発酵由来の酸味が、アルコール発酵由来の穏やかな風味・香味と相俟って、調和のとれた爽快でまろやかな酸味とすることができ、更に、酵母のもつダイアセチル還元能の作用により、ダイアセチルを大きく低減することにより、ダイアセチル濃度をビール又は発泡酒の閾値0.1mg/l以下に抑制することができる。乳酸発酵後の酵母によるアルコール発酵は、通常、発酵麦芽飲料又は麦芽代替発酵飲料の製造において採用されている発酵条件を採用することができる。すなわち、ビールや発泡酒のような発酵麦芽飲料又は麦芽代替発酵飲料の製造において通常行われている工程を採用できる。 In the method for producing a fermented malt beverage or a malt substitute fermented beverage of the present invention, alcoholic fermentation with yeast is performed after lactic acid fermentation with lactic acid bacteria. Alcohol fermentation by this yeast enables the sourness derived from lactic acid fermentation to be combined with the mild flavor and flavor derived from alcoholic fermentation to create a harmonious, refreshing and mellow sourness. By greatly reducing diacetyl due to the action of the acetyl reducing ability, the diacetyl concentration can be suppressed to a threshold of 0.1 mg / l or less for beer or happoshu. Alcohol fermentation by yeast after lactic acid fermentation can employ fermentation conditions generally employed in the production of fermented malt beverages or malt substitute fermented beverages. That is, the process normally performed in manufacture of fermented malt drinks, such as beer and sparkling liquor, or malt substitute fermented drinks can be employ | adopted.
酵母によるアルコール発酵が終了した発酵液は、適宜、別途製造した、乳酸発酵を行っていない、通常の発酵麦芽飲料又は麦芽代替発酵飲料の製法により製造された発酵麦芽飲料又は麦芽代替発酵飲料により調合し、目的とする香味に調整することが可能である。その際、ろ過工程以降に調合すれば、品質管理が比較的容易になるため、より好ましい。また、その際、最終的な乳酸菌量を100mlあたり、109〜1011個とするために、充填工程前に、別途一般的な乳酸菌培養方法で培養した同じ菌を添加して、調整することが可能である。 The fermented liquor after the alcoholic fermentation by yeast is appropriately prepared separately, and is prepared by a fermented malt beverage or a malt substitute fermented beverage produced by a normal fermented malt beverage or malt substitute fermented beverage that is not subjected to lactic acid fermentation. However, it is possible to adjust the target flavor. In that case, if it mixes after a filtration process, since quality control will become comparatively easy, it is more preferable. At that time, in order to make the final amount of lactic acid bacteria to 10 9 to 10 11 per 100 ml, the same bacteria separately cultured by a general lactic acid bacteria culture method should be added and adjusted before the filling step. Is possible.
本発明の発酵麦芽飲料又は麦芽代替発酵飲料を、調和のとれたまろやかな酸味と穏やかな香味を有するビール又は発泡酒とするためには、最終製品の乳酸量が300〜3000mg/lで、かつその場合のpHが3.8を下回らないように調整することが好ましい。同時に、抗アレルギー活性を有する乳酸菌の濃度としては、乳酸菌が発酵麦芽飲料又は麦芽代替発酵飲料100mlあたり、109〜1011個存在することが望ましい。さらに、ダイアセチル濃度がビール又は発泡酒の閾値以下0.1mg/lとすることが重要である。本発明において製造され抗アレルギー機能を有する発酵麦芽飲料又は麦芽代替発酵飲料の乳酸菌による抗アレルギー活性は、該発酵麦芽飲料又は麦芽代替発酵飲料を、平均的な市場滞留期間を経過した期間、すなわち6ヶ月の間保存した場合であっても変化しない。 In order to make the fermented malt beverage or the malt substitute fermented beverage of the present invention beer or happoshu having a harmonious, mild acidity and mild flavor, the lactic acid content of the final product is 300 to 3000 mg / l, and It is preferable to adjust so that the pH in that case does not fall below 3.8. At the same time, the concentration of lactic acid bacteria having antiallergic activity is desirably 10 9 to 10 11 lactic acid bacteria per 100 ml of fermented malt beverage or malt substitute fermented beverage. Furthermore, it is important that the diacetyl concentration be 0.1 mg / l or less than the threshold of beer or happoshu. The antiallergic activity by the lactic acid bacteria of the fermented malt beverage or the malt substitute fermented beverage produced in the present invention is that the fermented malt beverage or the malt substitute fermented beverage has passed through an average market residence period, that is, 6 Even if stored for months, it does not change.
以下、実施例により本発明をより具体的に説明するが、本発明の技術的範囲はこれらの例示に限定されるものではない。 EXAMPLES Hereinafter, although an Example demonstrates this invention more concretely, the technical scope of this invention is not limited to these illustrations.
糖度14°Pに調整したホップなしの麦芽汁に、同麦芽汁にて32℃、24時間、前培養した乳酸菌Lactobacilllus paracasei KW3110株を1w/w%添加し、32℃で乳酸発酵を行った。(初期乳酸菌数は106cells/ml)。乳酸発酵槽は容量20Lで、攪拌速度を10rpmとし、槽内は窒素ガスで置換した状態とした。槽内はやや陽圧になる程度とし、通気は実施しなかった。発酵は48時間実施し、途中24時間まではpHが4.8を下回らないよう水酸化ナトリウムを添加した。発酵液は80℃×30秒のプレート式熱交換器により殺菌した。得られた発酵液は100ml当たりLactobacilllus paracasei KW3110株を8.0×1010個含み、やや甘さが目立つものの、非常に爽快でまろやかな酸味と麦芽汁の甘味を兼ね備えた香味であった。また、乳酸発酵液の組成は表1の通りであった。尚、殺菌後の菌数はリアルタイムPCRによる方法により測定した。即ち、サンプルを遠心分離し(15000回転、 室温、 5分)、沈殿物をTEバッファーに懸濁し、次に、菌体懸濁液にグラスビーズ(50−212microns、SIGMA社)を加え、ボルテックスミキサー(Model Vortex-Genie 2)にチューブを逆さ向きにセットして2分間激しく撹拌し、菌体を破砕し、遠心分離(15000回転, 室温、 5分)した上清をDNAサンプルとして使用した。一方、リアルタイムPCRの機器は Roche 社 LightCycler を使用し、反応は FastStart DNA Master SYBR Green I を用いた。MgCl2濃度は3mMとし、L.paracasei 検出用プライマーとして、
PARA;5’-CACCGAGATTCAACATGG-3’(配列番号1)
Y2;5’-CCCACTGCTGCCTCCCGTAGGAGT-3’(配列番号2)
を使用した。
1 w / w% of lactic acid bacteria Lactobacilllus paracasei KW3110 strain pre-cultured in the same wort for 24 hours at 32 ° C. was added to the hopless wort adjusted to a sugar content of 14 ° P., and lactic acid fermentation was performed at 32 ° C. (The initial number of lactic acid bacteria is 10 6 cells / ml). The lactic acid fermentation tank had a capacity of 20 L, the stirring speed was 10 rpm, and the inside of the tank was replaced with nitrogen gas. The tank was set to a slightly positive pressure and was not vented. Fermentation was carried out for 48 hours, and sodium hydroxide was added so that the pH did not drop below 4.8 until 24 hours. The fermentation broth was sterilized by a plate heat exchanger of 80 ° C. × 30 seconds. The obtained fermented broth contained 8.0 × 10 10 Lactobacilllus paracasei KW3110 strains per 100 ml, and although it was somewhat sweet, it had a very refreshing and mellow acidity and a sweet taste of malt juice. The composition of the lactic acid fermentation broth was as shown in Table 1. The number of bacteria after sterilization was measured by a method using real-time PCR. Specifically, the sample was centrifuged (15000 rpm, room temperature, 5 minutes), the precipitate was suspended in TE buffer, glass beads (50-212 microns, SIGMA) were then added to the cell suspension, and the vortex mixer was added. The tube was set upside down on (Model Vortex-Genie 2), vigorously stirred for 2 minutes, the cells were crushed, and centrifuged (15000 rpm, room temperature, 5 minutes), and the supernatant was used as a DNA sample. On the other hand, Roche LightCycler was used as a real-time PCR instrument, and FastStart DNA Master SYBR Green I was used for the reaction. MgCl 2 concentration is 3 mM, and L. paracasei detection primer
PARA; 5'-CACCGAGATTCAACATGG-3 '(SEQ ID NO: 1)
Y2; 5′-CCCACTGCTGCCTCCCGTAGGAGT-3 ′ (SEQ ID NO: 2)
It was used.
この発酵液を糖度14°Pに調整したホップあり麦芽汁を同量添加し、ビール
酵母(Saccharomyses cerevisiae)を0.6w/w%添加し、10℃で1週間発
酵、約1ヶ月の貯蔵を経て、アルコールを5.5v/v%に調整した後に充填を
行った。このビールは100ml当たりKW3110株を2.5×1010cells
/ml含み、香味はやわらかな酸味と麦芽発酵飲料特有の爽快感が調和した味覚
を有していた。この麦芽発酵飲料の組成は表2の通りであった。
Add the same amount of hopped wort adjusted to 14 ° P sugar content, add 0.6 w / w% brewer's yeast (Saccharomyses cerevisiae), ferment at 10 ° C for 1 week, and store for about 1 month. Then, filling was performed after adjusting the alcohol to 5.5 v / v%. This beer contains 2.5 × 10 10 cells of KW3110 strain per 100 ml
/ Ml, and the flavor had a taste that harmonized the soft sourness and the refreshing feeling peculiar to the malt fermented beverage. The composition of this malt fermented beverage was as shown in Table 2.
(乳酸菌のin vitroにおける抗アレルギー能の評価)
1.試料
抗アレルギー活性測定用の各発酵液の一部を、9000Gの遠心分離処理し、得られた沈殿物を回収・滅菌水に懸濁後、さらに、500〜1000Gの遠心分離処理を行った。その後、その上清について3000Gの遠心分離処理し、得られた沈殿物を凍結乾燥し、PBSに懸濁した。
(Evaluation of antiallergic ability of lactic acid bacteria in vitro)
1. Sample A part of each fermentation broth for measuring antiallergic activity was centrifuged at 9000 G, and the resulting precipitate was collected and suspended in sterilized water, and then centrifuged at 500 to 1000 G. Thereafter, the supernatant was centrifuged at 3000 G, and the resulting precipitate was lyophilized and suspended in PBS.
2.実験動物、飼育
7−10週齢BALB/Cマウス(チャールズリバー)にday0とday6に卵白アルブミン(OVA)1mgをアジュバントであるAlum 2mgと共に腹腔内注射した。day13に解剖し、脾臓を単離・リンパ球を調製した。
2. Experimental animals, rearing 7-10 week old BALB / C mice (Charles River) were intraperitoneally injected with day 0 and day 6 with 1 mg of ovalbumin (OVA) together with 2 mg of adjuvant Alum. Day 13 was dissected and the spleen was isolated and lymphocytes were prepared.
3.脾細胞IL−4、IL−12の測定
IL−4、IL−12の測定は、0ptEIA ELISA Set(ベクトン・ディッキンソン)を用いて測定した。
3. Measurement of splenocytes IL-4 and IL-12 IL-4 and IL-12 were measured using 0ptEIA ELISA Set (Becton Dickinson).
4.測定条件
「2.実験動物、飼育」の方法で調製した脾臓リンパ球をRPMI1640(SIGMA)+10%FCS(ロシュ)+1mg OVA培地で2.5×106cells/mlになるように懸濁した。さらに試験する乳酸菌を0.1あるいは1μg/mlで添加した。1週間後に培養上清を回収し、Th1サイトカインとしてIL−12をTh2サイトカインとしてIL−4をそれぞれ測定した。
4). Measurement conditions Spleen lymphocytes prepared by the method of “2. Experimental animals, rearing” were suspended in RPMI 1640 (SIGMA) + 10% FCS (Roche) +1 mg OVA medium to 2.5 × 10 6 cells / ml. Further, lactic acid bacteria to be tested were added at 0.1 or 1 μg / ml. One week later, the culture supernatant was collected, and IL-12 was measured as Th1 cytokine and IL-4 was measured as Th2 cytokine.
5.実験結果
乳酸発酵、次いで、酵母発酵後、麦芽発酵飲料製品に含有している乳酸菌を、卵白アルブミンで感作させたマウス脾臓由来リンパ球を卵白アルブミン含有培地に懸濁し被検乳酸菌を添加して培養した結果、図1、2にある通り、被検乳酸菌としてL.paracasei KW3110株を用いた場合に比較して、50%以上のインターロイキン12産生量を示し、且つ、乳酸菌無添加コントロールの50%未満のインターロイキン4産生量を示し、その量は酵母発酵を経ても殆ど変化がなかった(コントロールは乳酸菌添加なしの測定)。
5). Experimental Results After lactic acid fermentation, then yeast fermentation, lactic acid bacteria contained in the malt fermented beverage product were sensitized with ovalbumin and mouse spleen-derived lymphocytes were suspended in ovalbumin-containing medium and the test lactic acid bacteria were added. As a result of culturing, as shown in FIGS. 1 and 2, compared to the case where L. paracasei KW3110 strain was used as the test lactic acid bacterium, the production amount of interleukin 12 was 50% or more and 50 of the lactic acid bacterium-free control was obtained. The amount of interleukin 4 produced was less than%, and the amount was almost unchanged even after yeast fermentation (control was measured without addition of lactic acid bacteria).
実施例1において、発酵・貯蔵が終了した麦芽発酵飲料を、より酸味の特徴を抑えた麦芽発酵飲料に調整するために、アルコール4.3v/v%、外観エキス1.1°Pのろ過済み麦芽発酵飲料に25%ブレンドした後に充填を行った。香味は、やわらかな酸味を有した軽快で爽快な味覚を有していた。この麦芽発酵飲料の組成は表3の通りであった。 In Example 1, in order to adjust the fermented malt beverage that had been fermented and stored to a malt fermented beverage with less sourness characteristics, alcohol 4.3% / v%, appearance extract 1.1 ° P filtered Filling was performed after blending 25% with a malt fermented beverage. The flavor had a light and refreshing taste with a soft sour taste. The composition of this malt fermented beverage was as shown in Table 3.
発酵麦芽飲料製品に含有している乳酸菌を、卵白アルブミンで感作させたマウス脾臓由来リンパ球を卵白アルブミン含有培地に懸濁し被検乳酸菌を添加して培養した結果、実施例1の最終製品と同等のインターロイキン12(IL−12)、及びインターロイキン4(IL−4)の産生量をそれぞれ示した。 As a result of suspending mouse spleen-derived lymphocytes sensitized with ovalbumin in lactic acid bacteria contained in the fermented malt beverage product in an ovalbumin-containing medium and adding the test lactic acid bacteria, the final product of Example 1 The production amounts of equivalent interleukin 12 (IL-12) and interleukin 4 (IL-4) are shown.
この麦芽発酵飲料製品を20〜30℃の室温に6ヶ月間保存した際のIL−12及びIL−4の産生量の継時変化は図3、4の通りである。その結果をみると、IL−12及びIL−4の産生量の継時的な変化は殆どみられず、いずれも高い活性が維持されていることが確認された。 Changes in production of IL-12 and IL-4 over time when the malt fermented beverage product is stored at room temperature of 20 to 30 ° C. for 6 months are shown in FIGS. As a result, it was confirmed that almost no change over time in the production amount of IL-12 and IL-4 was observed, and both maintained high activity.
Claims (2)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2004235642A JP4587368B2 (en) | 2004-08-12 | 2004-08-12 | Fermented malt beverage containing lactic acid bacteria having antiallergic function or malt substitute fermented beverage, and method for producing the same |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2004235642A JP4587368B2 (en) | 2004-08-12 | 2004-08-12 | Fermented malt beverage containing lactic acid bacteria having antiallergic function or malt substitute fermented beverage, and method for producing the same |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2006050979A JP2006050979A (en) | 2006-02-23 |
| JP4587368B2 true JP4587368B2 (en) | 2010-11-24 |
Family
ID=36028842
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2004235642A Expired - Lifetime JP4587368B2 (en) | 2004-08-12 | 2004-08-12 | Fermented malt beverage containing lactic acid bacteria having antiallergic function or malt substitute fermented beverage, and method for producing the same |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP4587368B2 (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105754770A (en) * | 2016-05-06 | 2016-07-13 | 史经略 | Cordyceps sobolifera fresh beer and brewing process thereof |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP4759472B2 (en) * | 2006-08-21 | 2011-08-31 | 株式会社創研 | Food and drink made from ancient rice |
| JP5523004B2 (en) * | 2008-07-31 | 2014-06-18 | 新潟県 | Food and drink having antiallergic function and method for producing the same |
| JP6278699B2 (en) * | 2013-12-27 | 2018-02-14 | アサヒビール株式会社 | Fermented malt beverage |
| JP6479432B2 (en) * | 2014-11-20 | 2019-03-06 | キリン株式会社 | Fermented malt beverage with red juice |
| CN105543041A (en) * | 2016-01-30 | 2016-05-04 | 于伟刚 | Cyanidin-milk serum wine and preparation method thereof |
| JP7566466B2 (en) * | 2017-03-27 | 2024-10-15 | ナショナル ユニヴァーシティー オブ シンガポール | Alcoholic drinks |
| JP6869938B2 (en) * | 2018-11-22 | 2021-05-12 | キリンホールディングス株式会社 | Fermented malt beverage with red fruit juice |
| JP6998997B2 (en) * | 2020-07-22 | 2022-01-18 | アサヒビール株式会社 | Beer-taste beverages and methods for manufacturing beer-taste beverages |
| CN116515704B (en) * | 2023-05-16 | 2023-09-26 | 河北兴台酒业集团有限责任公司 | Making method and process of black bean sauce wine |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH02154638A (en) * | 1988-12-03 | 1990-06-14 | Glyco Kyodo Nyugyo Kk | Production of fermented milk with lactobacillus bifidus |
| JPH02303451A (en) * | 1989-05-17 | 1990-12-17 | Glyco Kyodo Nyugyo Kk | Yoghurt filled in container |
| JP2888862B2 (en) * | 1989-05-29 | 1999-05-10 | 麒麟麦酒株式会社 | Production method of fermented beverage |
| JP2000060531A (en) * | 1998-08-12 | 2000-02-29 | Kyowa Hakko Kogyo Co Ltd | Shochu manufacturing method |
| JP4512265B2 (en) * | 2000-12-26 | 2010-07-28 | 株式会社ヤクルト本社 | Lactic acid bacteria culture supernatant, method for producing the same, and external preparation for skin using the supernatant |
-
2004
- 2004-08-12 JP JP2004235642A patent/JP4587368B2/en not_active Expired - Lifetime
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105754770A (en) * | 2016-05-06 | 2016-07-13 | 史经略 | Cordyceps sobolifera fresh beer and brewing process thereof |
Also Published As
| Publication number | Publication date |
|---|---|
| JP2006050979A (en) | 2006-02-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Sumby et al. | Measures to improve wine malolactic fermentation | |
| Canonico et al. | Torulaspora delbrueckii in the brewing process: A new approach to enhance bioflavour and to reduce ethanol content | |
| Rice et al. | Application of mannitol producing Leuconostoc citreum TR116 to reduce sugar content of barley, oat and wheat malt-based worts | |
| CN101346458B (en) | Microbiologically stabilized beer | |
| JP5763416B2 (en) | Method for producing low alcohol fermented malt beverage | |
| RU2610671C2 (en) | Method for industrial production of kvass beverage | |
| CN111793590B (en) | Brewing microbial inoculum for acidized beer and application thereof | |
| CN105283536A (en) | Process for preparing fermented beverages and beverages prepared therefrom | |
| CN111004752A (en) | Ethanol-resistant lactobacillus plantarum and application thereof in fermented food | |
| JP2019088212A (en) | Flavor improving agent for beverage | |
| WO2012033229A1 (en) | Process for production of distilled spirit | |
| JP4587368B2 (en) | Fermented malt beverage containing lactic acid bacteria having antiallergic function or malt substitute fermented beverage, and method for producing the same | |
| da Silva et al. | Survival of the probiotic strain Lacticaseibacillus paracasei subsp. paracasei F19 in high-hopped beers | |
| JP5540206B2 (en) | Fermented honey, its production method and yeast exhibiting honey fermentation | |
| JP4325834B2 (en) | Alcohol-containing beverage and method for producing the same | |
| JP2024523731A (en) | Method for producing malt fermentation liquid | |
| Manshin et al. | Comparison of the yeast Saccharomyces cerevisiae var. boulardii and top-fermenting brewing yeast strains during the fermentation of model nutrient media and beer wort | |
| JP3822415B2 (en) | Yeast mutant for alcoholic beverage production and method for producing alcoholic beverages using the yeast mutant | |
| JPS6153008B2 (en) | ||
| WO2017214673A1 (en) | A yeast strain and uses thereof | |
| Nakatani et al. | Characterization and application of Lachancea thermotolerans isolates for sake brewing | |
| CN116376775A (en) | A strain of Lactobacillus helveticus with high ethanol tolerance and its application | |
| Ciani et al. | Nonconventional yeasts in craft beer brewing | |
| KR102289292B1 (en) | Method for manufacturing of draft rice wine with an increased shelf life through the separation processing of lees and draft rice wine using the same | |
| JP2003116523A (en) | Yeast isolated from cherry blossoms, method for obtaining the same, and method for producing sake and other foods and beverages using the yeast |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20070309 |
|
| A711 | Notification of change in applicant |
Free format text: JAPANESE INTERMEDIATE CODE: A712 Effective date: 20070730 |
|
| RD03 | Notification of appointment of power of attorney |
Free format text: JAPANESE INTERMEDIATE CODE: A7423 Effective date: 20070914 |
|
| A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20090501 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20100324 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20100519 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20100624 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20100728 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20100819 |
|
| TRDD | Decision of grant or rejection written | ||
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20100902 |
|
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20100903 |
|
| R150 | Certificate of patent or registration of utility model |
Ref document number: 4587368 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20130917 Year of fee payment: 3 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| EXPY | Cancellation because of completion of term |